home / stock / ivevf / ivevf articles

IVEVF Articles, Inventiva SA - From 11/21/23

Stock Information
Company Name: Inventiva SA
Stock Symbol: IVEVF
Market: OTC
Website: inventivapharma.com
Menu
IVEVF IVEVF Quote IVEVF Short IVEVF News IVEVF Articles IVEVF Message Board
Get IVEVF Alerts

News, Short Squeeze, Breakout and More Instantly...
Inventiva reports 2023 Third Quarter Financial Information¹ | Benzinga

Cash and cash equivalents at €43.8 million, short-term deposits at €0.03 million2, and long-term deposit at €5.0 million3 as of September 3...
Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023 | Benzinga

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. Two additional sc...

Inventiva reports its 2023 first-half financial results and provides a corporate update | Benzinga

Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million1, and long-term deposit at €9.3 million2, as of June 30, 2...

Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea | Benzinga

Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position.   Under the exclusive lice...
Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty certificates | Benzinga

Daix (France), Long Island City (New York, United States), August 31, 2023 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharma...

Previous 10 Next 10